Fashioning regulatory dendritic cells

What is currently in vogue?

Timucin Taner, A. W. Thomson

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Dendritic cells (DCs) are uniquely well-equipped antigenpresenting cells with remarkable plasticity, whose differentiation and function can be manipulated in vitro and in vivo. With increased understanding of their immunoregulatory properties, strategies to enhance DC tolerogenicity have emerged. Carefully fashioned DCs, the result of biological, pharmacological or genetic modification, hold promise as new cell-based therapies of organ allograft rejection and autoimmune diseases.

Original languageEnglish (US)
Pages (from-to)78-82
Number of pages5
JournalCurrent Opinion in Molecular Therapeutics
Volume6
Issue number1
StatePublished - Feb 1 2004
Externally publishedYes

Fingerprint

Dendritic Cells
Cell- and Tissue-Based Therapy
Autoimmune Diseases
Allografts
Pharmacology
In Vitro Techniques

Keywords

  • Autoimmunity
  • Dendritic cells
  • Immunotherapy
  • Tolerance
  • Transplantation

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery
  • Genetics(clinical)

Cite this

Fashioning regulatory dendritic cells : What is currently in vogue? / Taner, Timucin; Thomson, A. W.

In: Current Opinion in Molecular Therapeutics, Vol. 6, No. 1, 01.02.2004, p. 78-82.

Research output: Contribution to journalReview article

@article{b4eb6c0fe13b40c1a113bca88dbe7afa,
title = "Fashioning regulatory dendritic cells: What is currently in vogue?",
abstract = "Dendritic cells (DCs) are uniquely well-equipped antigenpresenting cells with remarkable plasticity, whose differentiation and function can be manipulated in vitro and in vivo. With increased understanding of their immunoregulatory properties, strategies to enhance DC tolerogenicity have emerged. Carefully fashioned DCs, the result of biological, pharmacological or genetic modification, hold promise as new cell-based therapies of organ allograft rejection and autoimmune diseases.",
keywords = "Autoimmunity, Dendritic cells, Immunotherapy, Tolerance, Transplantation",
author = "Timucin Taner and Thomson, {A. W.}",
year = "2004",
month = "2",
day = "1",
language = "English (US)",
volume = "6",
pages = "78--82",
journal = "Current Opinion in Molecular Therapeutics",
issn = "1464-8431",
publisher = "Current Drugs Ltd.",
number = "1",

}

TY - JOUR

T1 - Fashioning regulatory dendritic cells

T2 - What is currently in vogue?

AU - Taner, Timucin

AU - Thomson, A. W.

PY - 2004/2/1

Y1 - 2004/2/1

N2 - Dendritic cells (DCs) are uniquely well-equipped antigenpresenting cells with remarkable plasticity, whose differentiation and function can be manipulated in vitro and in vivo. With increased understanding of their immunoregulatory properties, strategies to enhance DC tolerogenicity have emerged. Carefully fashioned DCs, the result of biological, pharmacological or genetic modification, hold promise as new cell-based therapies of organ allograft rejection and autoimmune diseases.

AB - Dendritic cells (DCs) are uniquely well-equipped antigenpresenting cells with remarkable plasticity, whose differentiation and function can be manipulated in vitro and in vivo. With increased understanding of their immunoregulatory properties, strategies to enhance DC tolerogenicity have emerged. Carefully fashioned DCs, the result of biological, pharmacological or genetic modification, hold promise as new cell-based therapies of organ allograft rejection and autoimmune diseases.

KW - Autoimmunity

KW - Dendritic cells

KW - Immunotherapy

KW - Tolerance

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=3843082021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843082021&partnerID=8YFLogxK

M3 - Review article

VL - 6

SP - 78

EP - 82

JO - Current Opinion in Molecular Therapeutics

JF - Current Opinion in Molecular Therapeutics

SN - 1464-8431

IS - 1

ER -